MediVax AI
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $45M
Overview
An AI-driven biotech company accelerating the design and development of novel vaccines for infectious diseases.
Infectious Disease
Technology Platform
An AI/ML platform that analyzes pathogen and immune system data to predict optimal antigen designs and accelerate vaccine discovery.
Funding History
1Total raised:$45M
Series C$45M
Opportunities
Potential to dramatically shorten vaccine development timelines, which is critical for responding to epidemics and dealing with rapidly mutating viruses.
Risk Factors
High risk of platform validation; AI predictions must successfully translate into clinically effective vaccines.
Competitive Landscape
Competes with other AI-driven drug discovery companies like Atomwise and Absci, as well as internal R&D at large pharma.